Melody Cobleigh to Protein Kinase Inhibitors
This is a "connection" page, showing publications Melody Cobleigh has written about Protein Kinase Inhibitors.
Connection Strength
0.659
-
Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway. Breast Cancer Res Treat. 2019 Sep; 177(2):325-333.
Score: 0.640
-
Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer. Breast Cancer Res Treat. 2009 May; 115(1):115-21.
Score: 0.019